Avantor, Inc. (AVTR)

Market Cap	14.44B
Revenue (ttm)	6.82B
Net Income (ttm)	309.60M
Shares Out	680.61M
EPS (ttm)	0.45
PE Ratio	47.15
Forward PE	19.73
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,221,589
Open	21.01
Previous Close	21.02
Day's Range	20.95 - 21.47
52-Week Range	19.59 - 28.00
Beta	1.29
Analysts	Buy
Price Target	27.69 (+30.55%)
Earnings Date	Feb 12, 2025

About AVTR

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education an...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: May 17, 2019
• Employees: 7,570
• Stock Exchange: NYSE
• Ticker Symbol: AVTR
• Website: https://www.avantorsciences.com

Financial Performance

In 2023, Avantor's revenue was $6.97 billion, a decrease of -7.26% compared to the previous year's $7.51 billion. Earnings were $321.10 million, a decrease of -51.52%.

Analyst Forecast

According to 14 analysts, the average rating for AVTR stock is "Buy." The 12-month stock price forecast is $27.69, which is an increase of 30.55% from the latest price.

Price Target

$27.69

(30.55% upside)

Analyst Consensus: Buy